With no known cure and a genetic basis that remains poorly understood, multiple sclerosis is a leading cause of progressive neurological impairment globally. In Newfoundland and Labrador, where MS prevalence is approximately three times the global average, the enrichment of familial cases suggests the potential to identify novel genetic drivers of the disease and the biological pathways that lead to neurodegeneration.

Like other health research, there is no guarantee this study will result in any significant breakthroughs or directy benefit participants or their families. By taking part in this study, you are contributing to scientific research which may eventually lead to meaningful changes in clinical care.

Questions about your rights as a participant in a research study? Contact the HREA Ethics Office. They are not involved with running this study. Call 709-864-8871 or email info@hrea.ca.